Abstract
In vivo biotelemetry studies have demonstrated that heart rate (HR) is progressively and rapidly reduced after administration of streptozotocin (STZ) and that the reduction in HR can be partially normalized with insulin replacement. Reductions in HR have also been reported in isolated perfused heart and superfused right atrial preparations suggesting that intrinsic defects in the heart are at least partly responsible for the bradycardia. The regional effects of STZ-induced diabetes mellitus (DM) on action potentials (APs) in the sinoatrial node (SAN), right and left atria and ventricles have been compared in the spontaneously beating Langendorff perfused rat heart 10–12 weeks after treatment. HR was significantly reduced in STZ-induced diabetic rat heart (174 ± 9 BPM) compared to controls (241 ± 12 BPM). The duration of AP repolarization at 50% and 70% from peak AP was significantly prolonged in SAN, right atrium and right ventricle from STZ-induced diabetic rat compared to age-matched controls. In the SAN AP duration (APD) at 50% and 70% were 51.7 ± 2.2 and 59.5 ± 2.3 ms in diabetic rat heart compared to 45.2 ± 1.7 and 50.0 ± 1.6 ms in controls, respectively. In contrast APD at 50% and 70% were not significantly altered in the left atrium and left ventricle. Regional defects in the expression and/or electrophysiology of SAN ion channels, and in particular those involved in AP repolarization, might underlie heart rhythm disturbances in the STZ-induced DM rat.
Similar content being viewed by others
References
Amos AF, McCarty DJ, Zimmet P (1997) The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabetic Med 14:S7–S85
Dhalla NS, Pierce GN, Innes IR, Beamish RE (1985) Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J␣Cardiol 1:263–281
Veglio M, Chinaglia A, Cavallo PP (2000) The clinical utility of QT interval assessment in diabetes. Diabetes Nutr Metab 13:356–365
Linnemann B, Janka HU (2003) Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study. Exp Clin Endocrinol Diabetes 111:215–222
Podlaha R, Falk A (1992) The prevalence of diabetes mellitus and other risk factors of atherosclerosis in bradycardia requiring pacemaker treatment. Horm Metab Res Suppl 26:84–87
Dai S, Thompson KH, McNeill JH (1994) One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate. Pharmacol Toxicol 74:101–109
Howarth FC, Qureshi MA, White E (2002) Effects of hyperosmotic shrinking on ventricular myocyte shortening and intracellular Ca(2+) in streptozotocin-induced diabetic rats. Pflügers Arch 444:446–451
Howarth FC, Jacobson M, Naseer O, Adeghate E (2005) Short-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats. Exp Physiol 90:237–245
Howarth FC, Jacobson M, Shafiullah M, Adeghate E (2006) Effects of insulin treatment on heart rhythm, body temperature and physical activity in streptozotocin-induced diabetic rat. Clin Exp Pharmacol Physiol 33:327–331
Li XS, Tanz RD, Chang KS (1989) Effect of age and methacholine on the rate and coronary flow of isolated hearts of diabetic rats. Br J Pharmacol 97:1209–1217
Hicks KK, Seifen E, Stimers JR, Kennedy RH (1998) Effects of streptozotocin-induced diabetes on heart rate, blood pressure and cardiac autonomic nervous control. J Auton Nerv Syst 69:21–30
Kofo-Abayomi A, Lucas PD (1988) A comparison between atria from control and streptozotocin-diabetic rats:the effects of dietary myoinositol. Br J Pharmacol 93:3–8
Howarth FC, Qureshi MA (2006) Effects of carbenoxolone on heart rhythm, contractility and intracellular calcium in streptozotocin-induced diabetic rat. Mol Cell Biochem 289:21–9
Boyett MR, Honjo H, Kodama I (2000) The sinoatrial node, a heterogeneous pacemaker structure. Cardiovasc Res 47:658–687
Ishikawa T, Kajiwara H, Kurihara S (1999) Alterations in contractile properties and Ca2+ handling in streptozotocin-induced diabetic rat myocardium. Am J Physiol 277:H2185–H2194
Loganathan R, Bilgen M, Al Hafez B, Smirnova IV (2006) Characterization of alterations in diabetic myocardial tissue using high resolution MRI. Int J Cardiovasc Imaging 22:81–90
Ruzicska E, Foldes G, Lako-Futo Z, Sarman B, Wellmann J, Szenasi G, Tulassay Z, Ruskoaho H, Toth M, Somogyi A (2004) Cardiac gene expression of natriuretic substances is altered in streptozotocin-induced diabetes during angiotensin II-induced pressure overload. J Hypertens 22:1191–1200
Grimm D, Jabusch HC, Kossmehl P, Huber M, Fredersdorf S, Griese DP, Kramer BK, Kromer EP (2002) Experimental diabetes and left ventricular hypertrophy:effects of beta-receptor blockade. Cardiovasc Pathol 11:229–237
Stadler K, Jenei V, Somogyi A, Jakus J (2004) Aminoguanidine prevents peroxynitrite production and cardiac hypertrophy in streptozotocin-induced diabetic rats. Orv Hetil 145:2491–2496
Hajinazarian M, Cosio FG, Nahman NSJ, Mahan JD (1994) Angiotensin-converting enzyme inhibition partially prevents diabetic organomegaly. Am J Kidney Dis 23:105–117
Marionneau C, Couette B, Liu J, Li H, Mangoni ME, Nargeot J, Lei M, Escande D, Demolombe S (2005) Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. J Physiol 562:223–234
Satoh H (2003) Sino-atrial nodal cells of mammalian hearts:ionic currents and gene expression of pacemaker ionic channels. J Smooth Muscle Res 39:175–193
Shinagawa Y, Satoh H, Noma A (2000) The sustained inward current and inward rectifier K+ current in pacemaker cells dissociated from rat sinoatrial node. J Physiol 523:593–605
Satoh H (2005) Suppression of pacemaker activity by Ginkgo biloba extract and its main constituent, bilobalide in rat sino-atrial nodal cells. Life Sci 78:67–73
Satoh H (2000) Comparative actions of cibenzoline and disopyramide on I(Kr) and I(Ks) currents in rat sino-atrial nodal cells. Eur J Pharmacol 407:123–129
Shigematsu S, Maruyama T, Kiyosue T, Arita M (1994) Rate-dependent prolongation of action potential duration in single ventricular myocytes obtained from hearts of rats with streptozotocin-induced chronic diabetes sustained for 30–32 weeks. Heart Vessels 9:300–306
Yaras N, Turan B (2005) Interpretation of relevance of sodium-calcium exchange in action potential of diabetic rat heart by mathematical model. Mol Cell Biochem 269:121–129
Magyar J, Rusznak Z, Szentesi P, Szucs G, Kovacs L (1992) Action potentials and potassium currents in rat ventricular muscle during experimental diabetes. J Mol Cell Cardiol 24:841–853
Raimondi L, De Paoli P, Mannucci E, Lonardo G, Sartiani L, Banchelli G, Pirisino R, Mugelli A, Cerbai E (2004) Restoration of cardiomyocyte functional properties by angiotensin II receptor blockade in diabetic rats. Diabetes 53:1927–1933
Casis O, Gallego M, Iriarte M, Sanchez-Chapula JA (2000) Effects of diabetic cardiomyopathy on regional electrophysiologic characteristics of rat ventricle. Diabetologia 43:101–109
Shimoni Y, Firek L, Severson D, Giles W (1994) Short-term diabetes alters K+ currents in rat ventricular myocytes. Circ Res 74:620–628
Jourdon P, Feuvray D (1993) Calcium and potassium currents in ventricular myocytes isolated from diabetic rats. J␣Physiol 470:411–429
Bracken NK, Woodall AJ, Howarth FC, Singh J (2004) Voltage-dependence of contraction in streptozotocin-induced diabetic myocytes. Mol Cell Biochem 261:235–243
Pandit SV, Giles WR, Demir SS (2003) A mathematical model of the electrophysiological alterations in rat ventricular myocytes in type-I diabetes. Biophys J 84:832–841
Pacher P, Ungvari Z, Nanasi PP, Kecskemeti V (1999) Electrophysiological changes in rat ventricular and atrial myocardium at different stages of experimental diabetes. Acta Physiol Scand 166:7–13
Shimoni Y, Ewart HS, Severson D (1998) Type I and II models of diabetes produce different modifications of K+ currents in rat heart:role of insulin. J Physiol 507:485–496
Wang DW, Kiyosue T, Shigematsu S, Arita M (1995) Abnormalities of K+ and Ca2+ currents in ventricular myocytes from rats with chronic diabetes. Am J Physiol 269:H1288–H1296
Shimoni Y, Severson D, Giles W (1995) Thyroid status and diabetes modulate regional differences in potassium currents in rat ventricle. J Physiol 488:673–688
Qin D, Huang B, Deng L, El Adawi H, Ganguly K, Sowers JR, El Sherif N (2001) Downregulation of K(+) channel genes expression in type I diabetic cardiomyopathy. Biochem Biophys Res Commun 283:549–553
Choi KM, Zhong Y, Hoit BD, Grupp IL, Hahn H, Dilly KW, Guatimosim S, Lederer WJ, Matlib MA (2002) Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol 283:H1398–H1408
Wold LE, Ren J (2004) Streptozotocin directly impairs cardiac contractile function in isolated ventricular myocytes via a p38 map kinase-dependent oxidative stress mechanism. Biochem Biophys Res Commun 318:1066–1071
Acknowledgement
Thanks to Dr Andy James, University of Bristol, UK, for supplying the suction electrode.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Howarth, F.C., Al-Sharhan, R., Al-Hammadi, A. et al. Effects of streptozotocin-induced diabetes on action potentials in the sinoatrial node compared with other regions of the rat heart. Mol Cell Biochem 300, 39–46 (2007). https://doi.org/10.1007/s11010-006-9366-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-006-9366-5